2025-12-31 - Analysis Report
Okay, here's a comprehensive report on Northrop Grumman Corp (NOC) based on the data you provided.

**1. Performance vs. S&P 500 (VOO)**

*   **Company Overview:** Northrop Grumman Corp. is a global aerospace and defense technology company.
*   **NOC Cumulative Return:** 49.08%
*   **VOO Cumulative Return:** 102.21%
*   **Divergence:**
    *   Current: -53.4
    *   Relative Divergence: 5.2

**Analysis:** NOC has significantly underperformed the S&P 500 (VOO) over the period covered by the cumulative return data. The -53.4% divergence highlights this large gap. The relative divergence of 5.2 indicates that the current divergence is near the minimum end of its historical fluctuation range compared to VOO.

**Alpha, Beta Analysis:**

| Year      | CAGR    | MDD    | Alpha   | Beta    | Cap(B) |
| --------- | ------- | ------ | ------- | ------- | ------ |
| 2015-2017 | 46.0%   | 65.6%  | 17.0%   | 0.0     | 43.9   |
| 2016-2018 | -2.0%   | 74.3%  | -17.0%  | 0.0     | 35.1   |
| 2017-2019 | 17.0%   | 79.2%  | -5.0%   | 0.9     | 49.2   |
| 2018-2020 | -28.0%  | 79.9%  | -52.0%  | 0.8     | 43.6   |
| 2019-2021 | 43.0%   | 79.9%  | -4.0%   | 0.8     | 55.4   |
| 2020-2022 | 18.0%   | 79.9%  | 19.0%   | 0.3     | 78.1   |
| 2021-2023 | 24.0%   | 82.7%  | 23.0%   | 0.2     | 67.0   |
| 2022-2024 | -15.0%  | 82.7%  | -36.0%  | 0.2     | 67.2   |
| 2023-2025 | -1.0%   | 82.1%  | -68.0%  | 0.1     | 82.3   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows inconsistent performance with periods of strong growth (2015-2017, 2019-2021) and periods of decline (2016-2018, 2018-2020, 2022-2024).
*   **MDD:** Maximum Drawdown is consistently high, indicating significant volatility and risk.
*   **Alpha:** Alpha is often negative, suggesting underperformance compared to a benchmark index (likely the S&P 500). Some periods show positive alpha (2015-2017, 2020-2022, 2021-2023), indicating periods where NOC outperformed its expected return based on its beta.
*   **Beta:** Beta values are generally low (closer to 0) and have decreased over time, indicating lower volatility relative to the market. This suggests NOC's price movements are less correlated with the overall market, making it less sensitive to market fluctuations.
*   **Cap(B):** Market capitalization fluctuates over time.

**2. Recent Stock Price Fluctuations**

*   **Current Price:** 574.57
*   **Previous Close:** 577.78
*   **Change:** -0.56
*   **5-day SMA:** 578.426
*   **20-day SMA:** 565.1835
*   **60-day SMA:** 578.9707

**Analysis:** The current price is slightly below the previous close, and the 5-day and 60-day Simple Moving Averages (SMAs) are above the current price, while the 20-day SMA is below. This suggests recent price weakness. The price falling below the 5-day and 60-day SMAs could be seen as a short-term bearish signal.

**3. Indicators & Signals**

*   **MRI (Market Risk Indicator):** 0.9 (Medium Investment Recommended)
*   **RSI (Relative Strength Index):** 64.59
*   **PPO (Percentage Price Oscillator):** 0.37
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90) Dividend_2.31 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** 0.5 (+): 단기상승 (short-term rise)
*   **Expected Return (%):** -158.8

**Analysis:**

*   **MRI:** The MRI suggests a medium level of investment risk.
*   **RSI:** An RSI of 64.59 is approaching overbought territory (typically above 70) but is still within a neutral range.
*   **PPO:** A slightly positive PPO suggests some short-term upward momentum, but the value is low, indicating that the momentum is not strong.
*   **Hybrid Signal:** The hybrid signal suggests a "Buy" recommendation, indicating that the system finds the stock attractive at the current price.
*   **Recent Divergence Change:** Indicates a short-term upward trend in relative divergence.
*   **Expected Return:** The significantly negative expected return (-158.8%) is concerning and suggests the model predicts significant underperformance over the next 2 years.

**4. Recent News & Significant Events**

*   **Rating Downgrade Argument:** Seeking Alpha article discusses a possible undervaluation despite a rating downgrade.
*   **Value Assessment after Pullback:** Yahoo Finance article analyzes the stock's value after a recent 5% price decrease.
*   **Implied Volatility Surge:** Nasdaq article notes increased volatility in Northrop Grumman stock options.
*   **Insider Sale:** Quiver Quantitative reports on an insider sale by a CVP & Pres. Mission Systems.
*   **Investment Outlook:** A ts2.tech article provides an overview of the stock's latest news, price targets, and investment outlook.
*   **Gains Ahead Chart:** DailyForex predicts possible gains ahead based on chart analysis.

**Analysis:** The news is mixed. A rating downgrade and insider selling are generally negative signals. However, articles discussing undervaluation and potential gains suggest some positive perspectives. The surge in implied volatility points to increased uncertainty and potential price swings.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.04)
*   **Target Price:** Average: 662.68, High: 770.00, Low: 533.00

**Analysis:** Analysts have a consensus "Buy" rating, with a significant premium between the current price and the average target price. However, it's important to note that the low target price is below the current trading price.

**5. Recent Earnings Analysis**

| 날짜         | EPS  | 매출        |
| ----------- | ---- | ----------- |
| 2025-10-21 | 7.69 | 10.42 B$ |
| 2025-07-22 | 8.17 | 10.35 B$ |
| 2025-04-22 | 3.33 | 9.47 B$ |
| 2024-10-24 | 7.02 | 10.00 B$ |
| 2025-10-21 | 7.02 | 10.00 B$ |

**Analysis:**  There seems to be a duplicated entry of 2025-10-21 in the table. Revenue has been relatively stable, but EPS has fluctuated. EPS dropped significantly in 2025-04-22. The most recent EPS figure (7.69) is above the prior year's value (7.02), which is positive.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | --------------- |
| 2025-09-30 | \$10.42B | 21.37%          |
| 2025-06-30 | \$10.35B | 21.35%          |
| 2025-03-31 | \$9.47B   | 16.69%          |
| 2024-12-31 | \$10.69B | 18.08%          |
| 2024-09-30 | \$10.00B | 21.07%          |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
| ------------ | --------- | ------ |
| 2025-09-30 | \$15.99B | 6.88%  |
| 2025-06-30 | \$15.47B | 7.59%  |
| 2025-03-31 | \$14.98B | 3.21%  |
| 2024-12-31 | \$15.29B | 8.27%  |
| 2024-09-30 | \$14.75B | 6.96%  |

**Analysis:**

*   **Revenue & Profit Margin:** Revenue has been generally stable, with a dip in Q1 2025. Profit margins are also relatively consistent, except for the notable drop in Q1 2025.
*   **Equity & ROE:** Equity has been gradually increasing. Return on Equity (ROE) has fluctuated, with a low in Q1 2025. The recent ROE is slightly lower than the previous year, suggesting a decrease in profitability relative to equity.

**7. Comprehensive Analysis (Summary)**

Overall, the information presents a mixed picture for Northrop Grumman (NOC).

*   **Underperformance:** NOC has significantly underperformed the S&P 500.
*   **Volatility:**  The stock exhibits relatively high volatility.
*   **Mixed Signals:** Technical indicators offer conflicting signals. Analyst consensus is "Buy," but target prices vary widely. Recent news includes both positive (undervaluation arguments) and negative (rating downgrade, insider selling) elements.
*   **Earnings:** Revenue is stable, but EPS and profit margins have shown some volatility. ROE shows some inconsistency as well.
*   **Expected Return:** The predicted negative future return (-158.8%) is a major concern.

**Conclusion:**

Based on this analysis, a cautious approach to NOC is warranted. While analysts see potential upside, the underperformance relative to the market, the volatile nature of the stock, and the negative expected return are significant red flags. Further investigation into the reasons behind the expected underperformance is crucial before making any investment decision. A closer look at the company's specific projects, contracts, and competitive landscape would also be helpful.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.